NCT02101476

An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.

A Randomized, Open Label,Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP (Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 114 (actual)
• Sponsor: Lotus Clinical Research, LLC · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the analgesic efficacy of Xartemis 15mg/650mg by mouth every 12 hours for the management of acute moderate to severe post operative pain to generic Oxycodone/APAP(acetaminophen) (Percocet) 10mg/650mg by mouth every 6 hours.

Conditions

• Post Operative Pain

Interventions

Type	Name	Description
DRUG	Percocet	10mg/650mg
DRUG	Xartemis	15mg/650mg

Timeline

• Start date: 2014-05-01
• Primary completion: 2014-08-01
• Completion: 2014-10-01
• First posted: 2014-04-02
• Last updated: 2018-04-09

Locations

1 site across 1 country: United States